Table 3 Ghrelin and obestatin expression in male breast cancer in relation to clinicopathological variables.
From: Ghrelin expression is associated with a favorable outcome in male breast cancer
Ghrelin | ρ | p-value | n (%) |
|---|---|---|---|
Tumor size | 0.04 | 0.58 | 175 (93) |
Node status | 0.04 | 0.66 | 158 (84) |
Age | 0.06 | 0.40 | 188 (99) |
ER | 0.20 | 0.007 | 186 (98) |
PgR | 0.15 | 0.05 | 186 (98) |
HER2 | −0.09 | 0.23 | 184 (97) |
NHG | 0.12 | 0.11 | 184 (97) |
Ki67 | −0.09 | 0.23 | 185 (98) |
Obestatin | |||
Tumor size | 0.04 | 0.62 | 172 (92) |
Node status | 0.03 | 0.74 | 155 (83) |
Age | −0.05 | 0.54 | 185 (99) |
ER | 0.11 | 0.15 | 184 (99) |
PgR | −0.25 | 0.001 | 184 (99) |
HER2 | 0.06 | 0.38 | 182 (98) |
NHG | 0.05 | 0.55 | 181 (97) |
Ki67 | −0.12 | 0.1 | 183 (98) |
Ghrelin | 0.34 | 0.000 | 186 (100) |
